Cancer Intervention and Surveillance Modeling Network (CISNET) (U01 Clinical Trial Not Allowed)

Federal funding opportunity RFA-CA-25-032 from National Institutes of Health (Department of Health and Human Services).

Program funding history

Synopsis

Who can apply

• Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
• County governments
• Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
• Independent school districts
• Public and State controlled institutions of higher education
• For profit organizations other than small businesses
• Special district governments
• Public housing authorities/Indian housing authorities
• City or township governments
• Native American tribal organizations (other than Federally recognized tribal governments)
• Others (see text field entitled "Additional Information on Eligibility" for clarification)
• State governments
• Native American tribal governments (Federally recognized)
• Small businesses
• Private institutions of higher education

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Applications Involving the NIH Intramural Research ProgramThe requests by NIH intramural scientists will be limited to the incremental costs required for participation. As such, these requests will not include any salary and related fringe benefits for career, career conditional or other Federal employees (civilian or uniformed service) with permanent appointments under existing position ceilings or any costs related to administrative or facilities support (equivalent to Facilities and Administrative or F&A costs). These costs may include salary for staff to be specifically hired under a temporary appointment for the project, consultant costs, equipment, supplies, travel, and other items typically listed under Other Expenses. Applicants should indicate the number of person-months devoted to the project, even if no funds are requested for salary and fringe benefits. If selected, appropriate funding will be provided by the NIH Intramural Program. Intellectual property will be managed in accord with established policy of NIH in compliance with Executive Order 10096, as amended, 45 CFR Part 7; patent rights for inventions developed in NIH facilities are NIH property unless NIH waives its rights. Should an extramural application include the collaboration with an intramural scientist, no funds for the support of the intramural scientist may be requested in the application. The intramural scientist may submit a separate request for intramural funding as described above. Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities…

The official record

Similar grants

• Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
  RFA-CA-27-021 · National Institutes of Health · closes October 19, 2026
• Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
  RFA-CA-27-020 · National Institutes of Health · closes October 19, 2026
• Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
  PAR-25-098 · National Institutes of Health · closes January 7, 2027
• Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
  PAR-25-167 · National Institutes of Health · closes January 7, 2027
• National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
  PAR-25-081 · National Institutes of Health · closes January 7, 2027
• Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
  PAR-25-379 · National Institutes of Health · closes January 7, 2027